Used in pharmaceutical research as a potent adenosine receptor antagonist, particularly targeting A1 and A2A receptors. This compound shows potential in the development of central nervous system agents, including treatments for Parkinson’s disease and other neurodegenerative disorders. Its structure allows for high selectivity and improved blood-brain barrier penetration, making it a valuable scaffold in designing novel therapeutics for cognitive and motor function disorders. Also investigated for anti-inflammatory and cardioprotective effects due to modulation of adenosine signaling pathways.